Tarsus Pharmaceuticals Income Statement (2019-2026) | TARS

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
1.24M0.34M0.54M15.28M10.00M2.50M1.87M13.08M27.61M40.81M48.12M66.41M78.33M102.66M118.70M151.67M162.05M173.91M
Cost of Revenue (Quarter)
0.07M-0.02M0.03M0.52M0.40M0.38M1.22M1.65M3.00M3.24M4.93M5.21M6.24M8.31M10.93M9.40M12.11M
Gross Profit (Quarter)
1.18M0.36M0.51M14.76M9.60M2.50M1.49M11.86M25.96M37.81M44.88M61.48M73.12M96.42M110.39M140.74M152.66M161.80M
Operating items
Research & Development (Quarter)
10.21M8.04M12.08M9.60M10.91M0.50M12.36M12.55M12.11M13.30M12.07M12.32M12.13M16.87M14.41M15.59M16.28M18.04M22.35M31.01M
Selling, General & Administrative (Quarter)
6.67M6.77M7.95M10.38M11.99M14.63M15.10M20.27M30.32M43.01M51.58M58.79M57.91M69.03M85.00M103.01M108.63M130.68M136.43M150.70M
Other Operating Expenses (Quarter)
0.07M-0.02M0.03M0.52M9.93M0.38M1.22M1.65M3.00M3.24M4.93M5.21M6.24M8.31M10.93M9.40M12.11M
Operating Expenses (Quarter)
16.95M14.79M20.06M20.50M22.91M25.06M27.45M32.82M42.81M57.53M65.30M74.11M73.28M90.83M104.61M124.84M133.23M159.64M168.18M193.82M
Operating Income (Quarter)
-15.71M-14.45M-19.52M-5.22M-22.91M-15.06M-24.95M-32.82M-40.94M-44.45M-37.68M-33.30M-25.16M-24.42M-26.28M-22.18M-14.53M-7.98M-6.12M-19.91M
EBIT (Quarter)
-15.71M-14.45M-19.52M-5.22M-22.91M-15.06M-24.95M-32.82M-40.94M-44.45M-37.68M-33.30M-25.16M-24.42M-26.28M-22.18M-14.53M-7.98M-6.12M-19.91M
Non-operating items
Non Operating Investment Income (Quarter)
0.01M-0.11M0.42M-0.01M2.81M
Interest & Investment Income (Quarter)
0.01M0.30M1.06M2.13M2.29M2.23M2.84M2.98M3.12M4.13M4.12M3.65M3.45M4.23M4.11M3.95M3.72M3.70M
Other Non Operating Income (Quarter)
0.01M-0.92M0.04M-0.26M-0.01M-0.64M0.01M0.02M-0.04M0.31M-0.18M-0.07M0.04M-0.08M0.10M0.13M-0.09M-0.28M
Non Operating Income (Quarter)
-0.33M-0.35M-0.72M-0.52M0.39M1.46M1.53M1.40M1.79M2.55M1.95M0.01M1.74M1.31M1.16M1.84M1.94M1.66M1.51M4.07M
Net income details
EBT (Quarter)
-15.70M-14.45M-19.84M-5.47M-22.48M-13.63M-23.34M-31.41M-38.95M-42.32M-35.55M-31.28M-23.49M-23.09M-25.04M-123.69M-12.68M-5.65M-4.53M-223.33M
Tax Provisions (Quarter)
-0.34M0.05M0.00M-0.01M2.40M2.72M
Profit After Tax (Quarter)
-15.70M-14.85M-20.24M-5.74M-22.52M-13.67M-23.42M-31.42M-39.13M-41.83M-35.73M-33.29M-23.42M-22.93M-25.21M-20.34M-12.34M-8.17M-7.65M-18.81M
Income from Non-Controlling Interests (Quarter)
-0.01M-0.06M0.00M0.05M0.01M0.01M-0.06M-0.11M0.52M-0.17M-0.09M-0.05M0.25M0.09M-0.68M-0.26M
Income from Continuing Operations (Quarter)
-15.36M-14.50M-19.84M-5.47M-22.47M-13.63M-23.34M-31.41M-38.95M-42.32M-35.55M-31.28M-23.49M-23.09M-25.04M-123.69M-12.68M-5.65M-6.93M-226.05M
Consolidated Net Income (Quarter)
-15.36M-14.50M-19.84M-5.47M-22.47M-13.63M-23.34M-31.41M-38.95M-42.32M-35.55M-31.28M-23.49M-23.09M-25.04M-123.69M-12.68M-5.65M-6.93M-226.05M
Income towards Parent Company (Quarter)
-15.36M-14.50M-19.84M-5.47M-22.47M-13.63M-23.34M-31.41M-38.95M-42.32M-35.55M-31.28M-23.49M-23.09M-25.04M-123.69M-12.68M-5.65M-6.93M-226.05M
Net Income towards Common Stockholders (Quarter)
-15.36M-14.50M-19.84M-5.47M-22.47M-13.63M-23.34M-31.41M-38.95M-42.32M-35.55M-31.28M-23.49M-23.09M-25.04M-123.69M-12.68M-5.65M-6.93M-226.05M
Additional items
EPS (Basic) (Quarter)
-0.74-0.71-0.96-0.22-0.84-0.55-0.87-1.17-1.27-1.44-1.01-0.83-0.61-0.61-0.64-2.92-0.30-0.14-0.16-5.21
EPS (Diluted) (Quarter)
-0.74-0.71-0.96-0.22-0.84-0.55-0.87-1.17-1.27-1.44-1.01-0.83-0.61-0.61-0.64-2.92-0.30-0.14-0.16-5.21
Shares Outstanding (Quarter)
20.64M20.55M20.71M24.33M26.66M24.62M26.74M26.82M30.62M29.38M35.30M37.82M38.38M37.60M39.35M42.36M42.61M41.78M42.96M43.39M
Shares Outstanding (Diluted) (Quarter)
20.64M20.55M20.71M24.33M26.66M24.62M26.74M26.82M30.62M29.38M35.30M37.82M38.38M37.60M39.35M42.36M42.61M41.78M42.96M43.39M
Shares Outstanding (Entity) (Quarter)
20.71M20.73M20.73M26.70M26.70M26.73M26.80M26.90M33.10M34.21M37.75M38.03M38.20M38.35M42.00M42.21M42.45M42.55M43.02M43.27M
EBITDA (Quarter)
-15.71M-14.45M-19.52M-5.22M-22.91M-15.06M-24.95M-32.82M-40.94M-44.45M-37.68M-33.30M-25.16M-24.42M-26.28M-22.18M-14.53M-7.98M-6.12M-19.91M
Interest Expenses (Quarter)
0.32M0.54M0.63M0.69M0.68M0.81M0.86M0.85M0.98M2.11M2.44M2.31M2.21M105.73M2.27M1.62M2.13M207.12M
Tax Rate (Quarter)
2.17%-0.37%-0.01%0.02%-53.00%-1.22%